bumetanide has been researched along with Angiomatosis Oculoorbital-Thalamic Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tyzio, R | 1 |
| Khalilov, I | 1 |
| Represa, A | 1 |
| Crepel, V | 1 |
| Zilberter, Y | 1 |
| Rheims, S | 1 |
| Aniksztejn, L | 1 |
| Cossart, R | 1 |
| Nardou, R | 1 |
| Mukhtarov, M | 1 |
| Minlebaev, M | 1 |
| Epsztein, J | 1 |
| Milh, M | 1 |
| Becq, H | 1 |
| Jorquera, I | 1 |
| Bulteau, C | 1 |
| Fohlen, M | 1 |
| Oliver, V | 1 |
| Dulac, O | 1 |
| Dorfmüller, G | 1 |
| Delalande, O | 1 |
| Ben-Ari, Y | 1 |
| Khazipov, R | 1 |
1 other study available for bumetanide and Angiomatosis Oculoorbital-Thalamic Syndrome
| Article | Year |
|---|---|
Inhibitory actions of the gamma-aminobutyric acid in pediatric Sturge-Weber syndrome.
Topics: Action Potentials; Bumetanide; Cerebral Cortex; Diazepam; Epilepsy; Excitatory Amino Acid Antagonist | 2009 |